Paper404363
Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited.
Houston WE and 3 others. J Infect Dis, 1977. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited. Papers, record 404363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/404363
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| Encephalitis Virus, Eastern Equine | Major topic |
| Encephalitis Viruses | Major topic |
| Immunoglobulin G | Major topic |
| Animals | |
| Antigen-Antibody Complex | |
| Female | |
| Haplorhini | |
| Immunity | |
| Immunity, Maternally-Acquired | |
| Immunization, Secondary | |
| Macaca | |
| Male | |
| Mice | |
| Semliki forest virus |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34853815 | Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody. | Med Res Arch | 2021 | https://conductscience.org/library/papers/34853815 | PubMed |
| 32907757 | Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes. | Vaccine | 2020 | https://conductscience.org/library/papers/32907757 | PubMed |
| 32580274 | Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/32580274 | PubMed |
| 26497515 | Fcγ receptor pathways during active and passive immunization. | Immunol Rev | 2015 | https://conductscience.org/library/papers/26497515 | PubMed |
| 26018152 | Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen. | J Virol | 2015 | https://conductscience.org/library/papers/26018152 | PubMed |
| 23836278 | Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23836278 | PubMed |
| 23637771 | Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery. | PLoS One | 2013 | https://conductscience.org/library/papers/23637771 | PubMed |
| 17609270 | Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells. | J Virol | 2007 | https://conductscience.org/library/papers/17609270 | PubMed |
| 16809300 | Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes. | J Virol | 2006 | https://conductscience.org/library/papers/16809300 | PubMed |
| 15664904 | Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens. | Infect Immun | 2005 | https://conductscience.org/library/papers/15664904 | PubMed |
| 15205919 | Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer. | Cancer Immunol Immunother | 2004 | https://conductscience.org/library/papers/15205919 | PubMed |
| 3877176 | Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies. | J Virol | 1985 | https://conductscience.org/library/papers/3877176 | PubMed |
| 226031 | Colostral immunity in piglets from sows vaccinated with inactivated Aujeszky disease virus vaccine. | Arch Virol | 1979 | https://conductscience.org/library/papers/226031 | PubMed |
| 110688 | Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine. | Infect Immun | 1979 | https://conductscience.org/library/papers/110688 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/404363
GET https://conductscience.org/api/papers/v1/404363/authors